Top Warren Buffett Stocks To Own For 2014

Neither DC nor Marvel will be the ones to profit if this summer proves an R-rated comic book movie has the chops to draw a wide audience. Who will? Comcast (NASDAQ: CMCSA  ) , and studio subsidiary NBCUniversal, says Fool contributor Tim Beyers in the following video.

Aug. 2 brings 2 Guns from BOOM! Studios. Two weeks later, Kick-Ass 2 kicks off. Both movies are smaller-budget comic book adaptations, with Kick-Ass 2 the sequel to 2010’s Kick-Ass. Universal is distributing both films, Tim says.

You can bet executives at Time Warner (NYSE: TWX  ) and Walt Disney (NYSE: DIS  ) will be watching carefully. Both have an interest in expanding their comic book movie lineups by offering darker fare. Of the two, Time Warner has been more willing to venture into R-rated territory, with DC Comics adaptations such as 2010’s RED, a commercial success that earned $199 million worldwide. A sequel debuts on July 19, during the weekend of the annual San Diego Comic-Con.

Top Warren Buffett Stocks To Own For 2014: ACCO Brands Corp (ACCO)

ACCO Brands Corporation, incorporated on October 26, 1970, is one of the suppliers of branded school and office products. The Company sells its products through many channels that include the office products resale industry as well as through mass retail distribution and e-tailers. It designs, develops, manufactures and markets a variety of traditional and computer-related office products, school supplies and paper-based time management products. Through a focus on research, marketing and innovation, it seeks to develop new products that meet the needs of its consumers and commercial end-users, and support its brands. ACCO Brands is organized into three business segments: ACCO Brands North America, ACCO Brands International and Computer Products Group. It sells its products primarily to markets located in the United States, Northern Europe, Canada, Brazil, Australia and Mexico. On May 1, 2012, it completed the merger (Merger) of the Mead Consumer and Office Products Busine ss (Mead C&OP) with a wholly-owned subsidiary of the Company.

Its office, school and calendar product lines use name brands such as AT-A-GLANCE, Day-Timer, Five Star, GBC, Hilroy, Marbig, Mead, NOBO, Quartet, Rexel, Swingline, Tilibra, Wilson Jones and many others. Its products and brands are not confined to one channel or product category and are designed based on preference. It manufactures approximately half of its products, and specify and source approximately the other half of its products, mainly from Asia. Its office products, such as stapling, binding and laminating equipment and related consumable supplies, shredders and whiteboards, are used by businesses. These business end-users purchase their products from its customers, which include commercial contract stationers, retail superstores, mass merchandisers, wholesalers, resellers, mail order and Internet catalogs, club stores and dealers. It also supplies some of its products directly to commer cial and industrial end-users. Its school products include n! otebooks, folders, decorative calendars, and stationery products. It distributes its school products primarily through traditional and online retail mass market, grocery, drug and office superstore channels. It also supplies private label products within the school products sector. Its calendar products are sold throughout all channels where it sells office or school products, and it also sell direct to consumers.

ACCO Brands North America and ACCO Brands International

ACCO Brands North America and ACCO Brands International manufacture, source and sell traditional office products, school supplies, calendar products and document finishing solutions. ACCO Brands North America comprises the U.S. and Canada, and ACCO Brands International comprises the rest of the world, principally Europe, Latin America, Australia, and Asia-Pacific.

Its office, school and calendar product lines use name brands such as AT-A-GLANCE, Day-Timer, Five Star, GBC, Hilroy, Marbig, Mead, NOBO, Quartet, Rexel, Swingline, Tilibra, Wilson Jones and many others. Its office products, such as stapling, binding and laminating equipment and related consumable supplies, shredders and whiteboards, are used by businesses. These business end-users purchase their products from its customers, which include commercial contract stationers, mass merchandisers, retail superstores, wholesalers, resellers, mail order and Internet catalogs, club stores and dealers. It also supplies some of its products directly to commercial and industrial end-users.

Its school products include notebooks, folders, decorative calendars, and stationery products. It distributes its school products primarily through traditional and online retail mass market, grocery, drug and office superstore channels. It also supplies private label products within the school products sector. Its calendar products are sold throughout all channels where it sells office or school products, and it also sells direct to consumers.

! Computer Products Group

The Computer Products Group designs, distributes, markets and sells accessories for laptop and desktop computers and tablets and smartphones. These accessories primarily include security products, iPad covers and keypads, smartphone accessories, power adapters, input devices such as mice, laptop computer carrying cases, hubs, docking stations and ergonomic devices. The Computer Products Group sells mostly under the Kensington, Microsaver and ClickSafe brand names, with the majority of its revenue coming from the U.S. and Western Europe.

All of its computer products are manufactured to its specifications by third-party suppliers, principally in Asia, and are stored and distributed from its regional facilities. Its computer products are sold primarily to consumer electronics retailers, information technology value-added resellers, original equipment manufacturers and office products retailers.

The Company co mpetes with, 3M, Avery Dennison, Blue Sky, Carolina Pad, Dominion BlueLine, Esselte, Fellowes, Franklin Covey, Hamelin, House of Doolittle, Newell Rubbermaid, Smead, Spiral Binding, Belkin, Fellowes, Logitech and Targus.

Advisors’ Opinion:

  • [By Will Ashworth]

    While some might consider private equity firms to be at the high-end of the cycle, I see Fortress just now coming into its own. Fortress recently announced it took a paper loss on Bitcoin. Not to worry, FIG’s 2013 distributable earnings per share increased by almost 70% to $0.88, its highest level since its IPO. I see it moving higher than $10 in 2014.

    Cheap Stocks to Buy: ACCO Brands (ACCO)

    I don’t know about you but I definitely use several of its products on a regular basis. In fact, right here on my desk beside my computer is a small, Five Star notebook for jotting down ideas. I grew up on Hilroy notebooks, a brand brought to the table in its 2012 merger with MeadWestvaco’s (MWV) Consumer and Office Products division. MWV shareholders received one-third of an ACCO share for every MWV share. Since the deal was completed, ACCO stock has lost 42% of its value.

  • [By John Kell]

    Acco Brands Corp.(ACCO) expects its 2013 results to come in ahead of analysts’ estimates as the office-products supplier projected fourth-quarter revenue that beat expectations. Shares of the company, whose brands include Day-Timer, At-a Glance and Mead, rose 5.1% to $6.59 in light premarket trading.

Top Warren Buffett Stocks To Own For 2014: Qlik Technologies Inc.(QLIK)

Qlik Technologies Inc. engages in the development, commercialization, and implementation of software products and related services for user-driven business intelligence that enables customers to make business decisions primarily in the Americas, Europe, the Asia-Pacific region, and Africa. It provides QlikView Business Discovery platform, which helps people create and share insights and analysis in groups and across organizations. Business users can explore data, ask and answer their own stream of questions, and follow their own path to insight on their own and in teams and groups. The company also offers maintenance and professional services. It sells its products to a range of industry verticals, including consumer packaged goods, financial services, pharmaceuticals, retail, manufacturing, technology, and healthcare through its direct sales force, as well as through an indirect channel partners comprising distribution partners, value-added resellers, system integrators, and original equipment manufacturers to license and support its software platform. The company was founded in 1993 and is headquartered in Radnor, Pennsylvania.

Advisors’ Opinion:

  • [By Lee Jackson]

    Qlik Technologies Inc. (NASDAQ: QLIK) is a favorite at Baird and was recently upgraded to buy at Jefferies. The company engages in the development, commercialization and implementation of software products and related services for user-driven business intelligence that enables customers to make business decisions primarily in the Americas, Europe, the Asia-Pacific region and Africa. It provides the QlikView Business Discovery platform, which helps people create and share insights and analysis in groups and across organizations. Its strength in business analytics and financial services may bode well after the IBM issues. The Baird price target for the stock is $33, and the consensus number is at $32.27. The stock closed Wednesday at $28.60.

  • [By John Udovich]

    Yesterday, small cap business intelligence stock MicroStrategy Incorporated (NASDAQ: MSTR) surged 18.44% after reporting better-than-expected third quarter earnings – meaning it might be a good idea to take a closer look at it along with small cap peers Actuate Corporation (NASDAQ: BIRT) and Qlik Technologies Inc (NASDAQ: QLIK) to see what they might offer small cap investors. After all, everyone is being inundated with huge amounts of data from multiple sources, but its the following small cap stocks that provide software platforms to help customers try to make sense of it all: 

Top Warren Buffett Stocks To Own For 2014: Urstadt Biddle Properties Inc. (UBP)

Urstadt Biddle Properties, Inc., a real estate investment trust (REIT), engages in the acquisition, ownership, and management of commercial real estate properties in the United States. Its properties primarily consist of neighborhood and community shopping centers, office buildings, and industrial properties in Fairfield County, Connecticut; Westchester and Putnam Counties, New York; and Bergen County, New Jersey. As of October 31, 2007, the company owned or had an equity interest in 39 properties containing approximately 3.7 million square feet of gross leasable area. As a REIT, it is not subject to federal income tax to the extent that it distributes at least 90% of its REIT taxable income to its stockholders. The company was founded in 1969 and is headquartered in Fairfield County, Connecticut.

Advisors’ Opinion:

  • [By Rich Smith]

    Urstadt Biddle Properties (NYSE: UBP  ) (NYSE: UBA  ) — the real estate investment trust with two tickers — now has two separate executives at the top of its corporate structure, as well.

Top Warren Buffett Stocks To Own For 2014: Riverbed Technology Inc.(RVBD)

Riverbed Technology, Inc. provides solutions to the fundamental problems associated with information technology performance across wide area networks (WANs) in the United States and internationally. It primarily offers Steelhead products, which enable its customers to improve the performance of their applications and access to their data across WANs, as well as supports the riverbed services platform. The company’s Steelhead product family includes the Steelhead Mobile client software application that provides mobile workers with LAN-like access to corporate files and applications; Virtual Steelhead appliance to extend the reach of WAN optimization; Cloud Steelhead, a solution that is purpose-built for public cloud computing environments; Central Management Console that provides centralized configuration, monitoring, and control for simplifying the process of deploying and managing Steelhead products distributed across a WAN; and Interceptor appliance, which allows organiz ations to scale their WAN optimization solutions. It sells Steelhead appliances to customers ranging from small office deployments to large headquarters and data center locations. The company also offers Cascade product line, which help organizations manage, secure, and optimize the availability and performance of global applications; Stingray product line, which provides virtual application delivery control; and Whitewater gateways, designed to accelerate, de-duplicate, secure, and store backup data sets in the public cloud. It serves customers in manufacturing, finance, technology, government, architecture, engineering and construction, professional services, utilities, healthcare and pharmaceuticals, media, and retail industries. The company sells its products directly through value-added resellers and distributors, service providers, and systems integrators, as well as through its sales force. Riverbed Technology, Inc. was founded in 2002 and is headquartered in San Fra n cisco, California.

Advisors’ Opinion:

  • [By Rich Bieglmeier]

    [Related -Riverbed Technology, Inc. (RVBD) Q3 Earnings Preview: On Target – At Best?]

    For Q1 2014, the company expects non-GAAP revenue of $262 million to $268 million and non-GAAP earnings of $0.21 to $0.23 per diluted share.

  • [By Eshna Basu]

    Juniper is optimistic about the wide acceptance of the SDN technology. Hence, it is working closely with technology partners such as IBM (IBM), Check Point (CHKP), Red Hat (RHT) and Riverbed (RVBD) to make SDN deployments easy and fast.

  • [By Victor Nguyen]

    (c) 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

      Most Popular 9 One-Time Penny Stocks Didn't Stay That Way Ford's Alan Mulally Talks Aluminum, His Future & His Favorite Ride #PreMarket Primer: Thursday, January 16: Another Triple-Digit Day Elon Musk: $35,000 Tesla Coming In Three Years #PreMarket Primer: Wednesday, January 15: Big Earnings Day Earnings Scheduled For January 16, 2014 Related Articles (RVBD) UPDATE: Citigroup Raises Price Target After Riverbed Tech Rejects Elliot Offer UPDATE: Bank of America Merill Lynch Initiates Coverage on Riverbed Technology Benzinga's M&A Chatter for Wednesday January 15, 2014 Market Wrap For January 15: Bulls Take Over As Economic Growth Remains Healthy Benzinga's M&A Chatter for Thursday January 9, 2014 Analysts React to Elliott Associates $19 Offer to Acquire Riverbed Technology Around the Web, We’re Loving… Lightspeed Trading Presents:

Top Warren Buffett Stocks To Own For 2014: Spectrum Brands Holdings Inc.(SPB)

Spectrum Brands Holdings, Inc., together with its subsidiaries, operates as a consumer products company worldwide. It offers consumer batteries, including alkaline and zinc carbon batteries, rechargeable batteries and chargers, and hearing aid batteries and other specialty batteries; pet supplies, such as aquatic equipment and supplies, dog and cat treats, small animal foods, clean up and training aids, health and grooming products, and beddings; and home and garden control products comprising household insect controls, insect repellents, and herbicides. The company also provides electric shaving and grooming devices; small appliances, including small kitchen appliances and home product appliances; electric personal care and styling devices; and portable lighting. Its sells its products through various trade channels, including retailers, wholesalers and distributors, hearing aid professionals, industrial distributors, and original equipment manufacturers primarily under t he Rayovac, Remington, Varta, George Foreman, Black & Decker, Toastmaster, Farberware, Tetra, Marineland, Nature?s Miracle, Dingo, 8-in-1, Littermaid, Spectracide, Cutter, Repel, Hot Shot, Black Flag, and TAT brands. The company was headquartered in Madison, Wisconsin. As of January 7, 2011, Spectrum Brands Holdings, Inc. operates as a subsidiary of Harbinger Group Inc.

Advisors’ Opinion:

  • [By Marc Bastow]

    Consumer products manufacturer Spectrum Brands (SPB) raised its quarterly dividend 20% to 30 cents per share, payable on Mar. 18 to shareholders of record as of Feb. 19.
    SPB Dividend Yield: 1.58%

Top Warren Buffett Stocks To Own For 2014: Genomic Health Inc (GHDX)

Genomic Health, Inc. (Genomic Health), incorporated in August 2000, is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Its Oncotype DX platform utilizes quantitative genomic analysis known as reverse transcription polymerase chain reaction (RT-PCR), in standard tumor pathology specimens to provide tumor-specific information, or the oncotype of a tumor. As of February 2012, Oncotype DX was evaluated in invasive breast cancer in 13 clinical studies involving more than 4,000 breast cancer patients worldwide. Genomic Health offers its Oncotype DX tests as a clinical service, where it analyzes the expression levels of genes in tumor tissue samples and provide physicians with a quantitative gene expression profile expressed as a single quantitative score, which it calls a R ecurrence Score, for invasive breast cancer and colon cancer and a DCIS Score for DCIS. Its Oncotype DX breast cancer test analyzes the expression levels of 21 genes and Oncotype DX colon cancer test analyzes the expression levels of 12 genes. In March 2012, the Company established a wholly owned subsidiary, InVitae Corporation.

Oncotype DX Platform

The Company’s Oncotype DX platform uses its RT-PCR approach to improve cancer treatment decisions. Its diagnostic approach correlates gene expression to clinical outcomes and provides an individualized analysis of each patient’s tumor. The Company has built a diagnostic infrastructure that allows it to move from research into development through to processing actual patient samples in its clinical reference laboratory. The Company offers Oncotype DX tests as clinical laboratory services. Its technology allows the Company to analyze tumor tissue samples in its clinical reference laboratory and provide physicians with genomic information specific to the patient’! s tumor. It analyzes tissues that are handled, processed and stored under routine clinical pathology laboratory practices.

Oncotype DX Breast Cancer Test

To develop its Oncotype DX breast cancer test, the Company evaluated 250 genes in three independent clinical studies, which identified a 21-gene panel whose composite gene expression profile can be represented by a breast cancer Recurrence Score. The Company conducted studies of its Oncotype DX breast cancer test with clinical samples from postmenopausal women with invasive breast cancer who were treated with aromatase inhibitors. In March 2010, the Journal of Clinical Oncology published results from a European study using its test to analyze tumor samples from over 1,200 patients in the ATAC (Arimedix, Tamoxifen, Alone or in Combination) trial, which established the use of aromatase inhibitors for adjuvant treatment of postmenopausal women with hormone receptor-positive breast cancer. The study demonstrated that, along with other standard measures, such as tumor size, its Oncotype DX breast cancer test contributes independently to provide a more complete picture of prognosis for N- and N+ patients treated with aromatase inhibitors.

In December 2011, the Company presented positive results from the ECOG E5194 DCIS clinical validation study at SABCS. The study met its primary endpoint by demonstrating that a pre-specified Oncotype DX DCIS Score can predict the risk of local recurrence, defined as either the development of a new invasive breast cancer or the recurrence of DCIS in the same breast. In December 2011, the Company made Oncotype DX available for patients with ductal carcinoma in situ (DCIS), of the breast, a pre-invasive form of breast cancer. The launch of Oncotype DX for DCIS patients was based on positive results presented from a clinical validation study of Oncotype DX breast cancer test in patients with DCIS, conducted by the Eastern Coop erative Oncology Group (ECOG), a clinical trials cooperative! group su! pported by the National Cancer Institute.

Oncotype DX Colon Cancer Test

The Company developed its gene panel by identifying 761 cancer-related genes through review of existing research literature and computer analysis of genomic databases. The 761 candidate genes were also examined to determine whether they would be useful beyond other key variables including tumor stage, tumor grade, lymph nodes examined and MMR/MSI. It selected a final set of 12 genes, which were then independently evaluated in a validation study of over 1,400 stage II colon cancer patients from the Quick and Simple and Reliable (QUASAR), randomized study of adjuvant chemotherapy in the United Kingdom. This international, multi-center randomized trial examined the recurrence risk and the benefit associated with 5-fluorouracil/leucovorin, or 5FU/LV, adjuvant chemotherapy. Gene expression was quantified by RT-PCR from manually microdissected FPE primary colon cancer tissue, and rec urrence-free interval, disease-free survival and overall survival were analyzed. In January 2012, the Company presented positive results of the first clinical decision making study of the Oncotype DX colon cancer test that shows that Recurrence Score result has a significant impact on treatment recommendations for stage II colon cancer patients.

The Company competes with General Electric Company, Hologic, Inc., Novartis AG, Myriad Genetics, Inc., Qiagen N.V., Response Genetics, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Roche Holding, Ltd, Siemens AG and Johnson & Johnson.

Advisors’ Opinion:

  • [By John Udovich]

    On Tuesday, small cap cancer diagnostic stock Myriad Genetics, Inc (NASDAQ: MYGN) jumped 11.42% in one day, meaning its worth taking a closer look at the stock along with the performance of small cap cancer diagnostic stocks like Rosetta Genomics Ltd (NASDAQ: ROSG) and Genomic Health, Inc (NASDAQ: GHDX) plus mid cap diagnostic stock Quest Diagnostics Inc (NYSE: DGX). I should mention that we have had Myriad Genetics in our SmallCap Network Elite Opportunity (SCN EO) portfolio since February 5th and we are already up 18.50% – a nice return in just two weeks time.

  • [By John Udovich]

    Large and small cap cancer stocks Gilead Sciences, Inc (NASDAQ: GILD), Celgene Corporation (NASDAQ: CELG), Veracyte (NASDAQ: VCYT), Genomic Health, Inc (NASDAQ: GHDX), Cell Therapeutics Inc (NASDAQ: CTIC) and MetaStat Inc (OTCMKTS: MTST) have all been producing a steady stream of news lately for biotech investors looking for a way to cash in on the growth in development of cancer treatments. Just consider the following news:

  • [By Sean Williams]

    What: Shares of Genomic Health (NASDAQ: GHDX  ) , a provider of genome-based clinical diagnostic tests, popped as much as 10% following the release of its first-quarter results.